.png){kind=logo}
- ESVONC
- Avenue Ceramique 222
- 6221 KX Maastricht
- The Netherlands
- Tel: +31(0)43 325 05 21
- office@esvonc.com
The scientific program for the 2023 ESVONC congress in Alicante is ready.
There will be no live streaming this year.
The Nurses program on Friday 26th & Saturday 27th May is visible under the separate tab in the top menu.
The Meliá Alicante Hotel will be the venue for the 2023 ESVONC Congress.
| Residents' Workshop on Scientific Writing | ||
| 15.00-15.45 | Study design part 1 - kindly sponsored by |
Craig Clifford |
| 15.45-16.30 | Study design part 2 - kindly sponsored by |
Craig Clifford |
| 16.30-17.00 | COFFEE BREAK | |
| 17.00-17.45 | Scientific writing: Reasons for Manuscript Rejections | Dan Chan |
| 17.45-18.15 | Scientific writing: Structuring a Scientific Paper | Dan Chan |
| 08.00-09.00 | REGISTRATION OPENS | |
| 08.45-09.00 | Welcome ESVONC to Alicante! | P. Clemente & J. Borrego |
| Themed Session: Nutrition & Cancer | ||
| 09.00-09.45 | Recent developments in nutritional modulation of neoplastic processes | Dan Chan |
| 09.45-10.30 | Scope for clinical applications of nutritional interventions for the oncological patient | Dan Chan |
| 10.30-11.00 | COFFEE BREAK – kindly sponsored by  |
|
| 11.00-11.45 | The Role of the Gut Microbiome in Cancer | Carolina Cortes |
| 11.45-12.30 | Modulating the Gut Microbiome: Researching Nutritional Approaches | Carolina Cortes |
| 12.30 - 13.00 | PANEL DISCUSSION | |
| 13.00-14.30 | Lunch & Poster Session | |
| 14.30-15.00 |
Nutritional Support for Pets with Cancer: a New Option SPONSORED TALK by |
Becky Mullis |
| Resident Abstracts | ||
| 15.00-15.15 | Safety and tolerability assessment of a combined protocol including lomustine, vincristine and prednisolone in cats with lymphoma | Sergio Vázquez Martínez |
| 15.15-15.30 | Feline high-grade alimentary lymphomas treated with COP or CHOP-based chemotherapy: a multicentric retrospective study of 57 cases | Grégoire Bernardo Marques |
| 15.30-15.45 | A multi-institutional comparative study of (L)COP/CHOP based chemotherapy with and without abdominal radiotherapy for feline gastrointestinal high grade lymphoma in 26 cats | Andrea Rey |
| 15.45-16.00 | First in dog: clinical remissions in dogs with diffuse large B-cell lymphoma (DLBCL) after radioimmunotherapy (RIT) using a murine anti-canine-CD22 monoclonal antibody | Catherine Ibisch |
| 16.00-16.30 | COFFEE BREAK – kindly sponsored by |
|
| General Abstracts | ||
| 16.30-16.45 | Association of allergic skin disease with the development of canine mast cell tumours (MCT): is a pruritic dog more prone to develop severe MCT? | Marianne Lappalainen |
| 16.45-17.00 | Retrospective analysis investigating the independence of histological and immunohistochemical prognostic factors from 199 canine mast cell tumours with follow up from their primary care practices | Katherine Boyd |
| 17.00-17.15 | Immunohistochemistry expression of immune checkpoint molecules PD-L1 and CTLA-4 in canine mast cell tumors | Mariana Ribeiro |
| 17.15-17.30 | Post-FDA approval analysis of Stelfonta® (tigilanol tiglate) use by veterinary oncologists for canine mast cell tumors | Pamela Jones |
| 17.30-18.00 |
ESVONC RESEARCH FUND PRESENTATION Presentation of the Fund and Approved Projects |
ESVONC CRF Committee |
| 19.00-21.00 |
Welcome Reception in Alicante! venue: Museo The Ocean Race kindly sponsored by |
|
| 08.00-09.00 | REGISTRATION OPENS | |
| Themed Session: Things I used to do but stopped and things I didn't do but started! | ||
| 09.00-09.20 | Lymph node mapping | Vincent Wavreille |
| 09.20-09.40 | Caudal maxillectomy | Nick Bacon |
| 09.40-10.00 | Insulinomas | Vincent Wavreille |
| 10.00-10.30 | COFFEE BREAK – kindly sponsored by |
|
| 10.30-10.50 | Bilateral adrenalectomies | Nick Bacon |
| 10.50-11.10 | Liver tumours | Vincent Wavreille |
| 11.10-11.30 | Amputation | Nick Bacon |
| 11.30-12.15 | PANEL DISCUSSION | |
| 12.15-14.30 | Lunch | |
| Resident Abstracts | ||
| 14.30-14.45 | Comparison of lymphoscintigraphy and near-infrared fluorescence lymphography for sentinel lymph node biopsy in dogs with integumentary mast cell tumors | Lavinia Elena Chiti |
| 14.45-15.00 | Near-infrared lymphography versus CT-Lymphography for primary lymph node detection in dogs with ASAC – a case series | Mirja Nolff |
| 15.00-15.15 | Weishaar’s classification system for nodal metastasis in sentinel lymph nodes: update on clinical outcome in 94 dogs with mast cell tumor | Elisa Maria Gariboldi |
| 15.15-15.30 | Clinical presentation and prognostic factors in 32 dogs with subcutaneous mast cell tumors treated with curative intent surgery | Xavier Escoda Llorens |
| 15.30-16.00 | COFFEE BREAK – kindly sponsored by |
|
| 16.00-16.30 |
Elevating Oncology Diagnosis with the Virtual Experience SPONSORED TALK by |
Lucia Carranza |
| General Abstracts | ||
| 16.30-16.45 | Grading radiation toxicity after chemoradiotherapy of canine urinary tract carcinomas with VRTOG_v2.0 | Carlotta Ahrens |
| 16.45-17.00 | Adjuvant dose-intensified doxorubicin protocol for splenic canine hemangiosarcoma: a pilot study | Miguel Garcia de la Virgen |
| 17.00-17.15 | Cytokines might tell us something - IL-12/IL-23p40 and IL-12 in Nova Scotia Duck Tolling Retrievers with cancer and autoimmune disease | Malin Nilsson |
| 17.15-17.30 | Plasma H3.1 nucleosome concentrations in dogs with various carcinomas | Heather Wilson-Robles |
| 18.00-... | Evening on your own! | |
| 08.00-09.00 | REGISTRATION OPENS | |
| Themed Session: Liquid biopsy | ||
| 09.00-09.45 | Liquid Biopsies in Diagnostic Pathology: A Brief History and Current and Future Applications | Jaime Modiano |
| 09.45-10.30 | Liquid biopsy in (human) oncology: clinical applications | Aitor Azkarate |
| 10.30-11.00 | COFFEE BREAK – kindly sponsored by |
|
| 11.00-11.45 | A Liquid Biopsy Platform for Novel Exosome-Based Cancer Diagnostics and Its Applications in Medicine and Veterinary Medicine | Jaime Modiano |
| 11.45-12.30 | Defining the Cancer Permissive Environment and Its Applications in Early Detection, Risk Assessment, and Strategic Prevention of Cancer | Jaime Modiano |
| 12.30-13.00 | PANEL DISCUSSION | |
| 13.00-14.30 | Lunch | |
| 14.00-15.00 | ANNUAL GENERAL MEETING (AGM) | ESVONC members |
| 15.00-15.30 |
The Use of OncoK9 Liquid Biopsy in Specialty Practice SPONSORED TALK by |
Andy Flory |
| Resident Abstracts | ||
| 15.30-15.45 | Evaluation of a novel liquid biopsy-based assay for cancer detection and monitoring in dogs | Suzanne Busser |
| 15.45-16.00 | Clinico-genomics analysis of 94 canine mammary tumors as an opportunity for targeted therapy | Lucas Rodrigues |
| 16.00-16.15 | Update World Meeting Tokyo 2024 | Tetsuya Kobayashi |
| 16.15-16.45 | COFFEE BREAK – kindly sponsored by |
|
| 16.45-17.15 |
It all started over a cup of coffee (the VCS experience) |
Sandi Strother (VCS Director) |
| General Abstracts | ||
| 17.15-17.30 | Proteomic profiling of feline fibrosarcoma and its adjacent peritumoral tissue | Enni Markkanen |
| 17.30-17.45 | Molecular characterization of canine FSA using spatially defined transcriptomics and proteomics | Daniel Fuchs |
| 17.45-18.00 | Fibroblast activation protein - a promising target for canine, feline and human soft tissue sarcoma | Patricia Beer |
| 20.00-... |
ESVONC's GALA DINNER venue: Castillo de Santa Bárbara kindly sponsored by
|
|